A declared objective of the EU is to provide support for the rural and poor regions of its member states. Recent research shows, however, that past EU budget allocations (in EU-15) can be explained, to a large extent, by measures of the distribution of voting power in the Council of Ministers deciding on the bulk of EU spending. Yet, empirical evidence indicates that also the “needs” of the mem...

Octapharma has read with great interest the report prepared by the Canadian Agency for Drugs and Technologies in Health (CADTH) on the cost-effectiveness of Octaplas® compared to FFP. This is the second version of this costeffectiveness report, which is entitled “Octaplas Compared with Fresh Frozen Plasma to Reduce the Risk of Transmitting Lipid-Enveloped Viruses: An Economic Analysis and Budge...

A thorough analysis of existing governance and accountability structures in a decentralised country is necessary before deciding to deliver development assistance directly to the regional level. This article examines the mechanism of donor-provided budget support at the local level in Indonesia and its potential impact on accountability structures. 2 Accountability is a key driver in the quest ...

Current study aimed to estimate clinical and economic outcomes of providing the Haemophilus influenzae type b (Hib) vaccination as a national vaccine immunization program in Thailand. A decision tree combined with Markov model was developed to simulate relevant costs and health outcomes covering lifetime horizon in societal and health care payer perspectives. This analysis considered children a...

The aim of this study is to compute the budget impact of adopting Kiovig, a new ready-to-use 10% liquid immunoglobulin preparation, as a treatment for primary immunodeficiency from the perspective of the Belgian health care payer. The analysis compared the “world with Kiovig” to the “world without Kiovig” and calculated how a change in the mix of immunoglobulins used to treat primary immunodefi...